secwatch.observer — SEC 8-K summary
======================================

Issuer:     Ginkgo Bioworks Holdings, Inc. (DNA)
CIK:        0001830214
Form:       8-K
Filed at:   2023-10-03T23:59:59+00:00
Accession:  0001628280-23-033551
Event type: other_material
Sentiment:  negative
Materiality: 0.70
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Zymergen subsidiary files Chapter 11; Ginkgo to acquire IP assets as stalking horse bidder
--------------------------------------------------------------------------------

- Zymergen Inc., a wholly-owned subsidiary of Ginkgo, filed voluntary Chapter 11 petitions on October 3, 2023 in Delaware.
- Neither Ginkgo nor its other subsidiaries filed for bankruptcy; Ginkgo remains well capitalized with $1.1B cash as of Q2 2023.
- Ginkgo entered an asset purchase agreement as stalking horse bidder to acquire exclusive rights to substantially all Zymergen IP assets.
- Bid includes $5M cash and assumption of up to $77M in future liabilities (lease, employee compensation and severance).
- Existing non-exclusive license for Zymergen's databases, automation, and software remains unaffected by the bankruptcy process.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1830214/000162828023033551/0001628280-23-033551-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1830214/000162828023033551/dna-20231003.htm
  HTML page:      https://secwatch.observer/filing/0001628280-23-033551

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer